For Healthcare Professionals: Bladder Cancer

Our team of specialists in urology, medical oncology, urologic surgery, radiation oncology, pathology, and radiology diagnose and treat nearly 400 patients with bladder cancer annually.  In addition to expertise in minimally invasive surgery for noninvasive bladder cancer and post-operative Calmette-Guérin (BCG) therapy for patients at high risk of recurrence, our urologic surgeons have extensive experience in cystectomy for invasive bladder cancer; we perform approximately 250 radical cystectomy operations each year.


We also offer a range of bladder preservation and reconstructive options and are working to develop new techniques to further improve radiation therapy via intensity-modulated radiation therapy (IMRT) and image-guided radiotherapy (IGRT). Our first-line treatment for metastatic bladder cancer includes standard chemotherapy regimens as well as access to novel drug regimens through clinical trial enrollment.

Referring a Patient

Call 877-284-5246
Mon–Fri, 8:30 AM–5:30 PM, ET

Find an Expert | See Clinical Trials | Request a Pathology Consult

More Science. Less Fear.
It’s Time to Change How the World Treats Cancer.

Learn how we’re making what was impossible yesterday possible today.

Prediction Tools

Use our online nomogram to estimate risk of cancer recurrence after surgery for primary invasive bladder cancer. Results can help physicians and patients make important treatment decisions.

Pictured: Robert Motzer
Sidney Kimmel Center for Prostate and Urologic Cancers

Our state-of-the-art treatment center is focused entirely on genitourinary cancers — tumors of the prostate, kidney, bladder, or testicle.

Pictured: S. Machele Donat
Bladder Cancer Information for Your Patients

The Memorial Sloan Kettering approach to diagnosis and treatment of bladder cancer in patient-friendly language.

E-Publications for Medical Professionals

Stay up-to-date on Memorial Sloan Kettering advances in your areas of interest.

Subscribe to OncoNotes »

Leading Edge Options for the Treatment of Bladder Cancer

Urologic surgeon Bernard Bochner discusses the prevalence of bladder cancer in the United States, and novel approaches to treatment.

Clinical Trials in Neoadjuvant Therapy for Bladder Cancer

Medical oncologist Dean Bajorin describes novel chemotherapy drugs in development at Memorial Sloan Kettering that may be given before bladder cancer surgery.

Treatment Strategies for Muscle Invasive Bladder Cancer

Medical oncologist Dean Bajorin talks about combining chemotherapy or radiation with surgery to treat patients with advanced bladder cancer.

Leading Edge Options
Neoadjuvant Therapy Trials
Muscle Invasive Cancer